{{Rsnum
|rsid=3218038
|Gene=CCNE1
|Chromosome=19
|position=29814988
|Orientation=plus
|GMAF=0.1304
|Gene_s=CCNE1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 96.5 | 3.5 | 0.0
| HCB | 60.3 | 32.4 | 7.4
| JPT | 60.7 | 30.4 | 8.9
| YRI | 67.3 | 28.6 | 4.1
| ASW | 66.7 | 29.8 | 3.5
| CHB | 60.3 | 32.4 | 7.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 90.9 | 9.1 | 0.0
| LWK | 65.5 | 31.8 | 2.7
| MEX | 60.3 | 32.8 | 6.9
| MKK | 67.8 | 32.2 | 0.0
| TSI | 86.9 | 13.1 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23185313
|Title=Association of Germline Variation in CCNE1 and CDK2 with Breast Cancer Risk, Progression and Survival among Chinese Han Women
|OA=1
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=18281541
|Title=Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
|OA=1
}}

{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}